Automated Hippocampal Subfield Measures as Predictors of Conversion from Mild Cognitive Impairment to Alzheimer’s Disease in Two Independent Cohorts

Brain Topography

Volumn 28, Issue 5, 2015, Pages 746-759

  Khan, Wasim ^a   Westman, Eric ^a,b   Jones, Nigel ^a,h   Wahlund, Lars Olof ^b   Mecocci, Patrizia ^c   Vellas, Bruno ^d   Tsolaki, Magda ^e   Kłoszewska, Iwona ^f   Soininen, Hilkka ^g   Spenger, Christian ^b   Lovestone, Simon ^a   Muehlboeck, J Sebastian ^a,h   Simmons, Andrew ^a,h  

^a KING'S COLLEGE LONDON   (United Kingdom)

^b KAROLINSKA INSTITUTE   (Sweden)

^c UNIVERSITY OF PERUGIA   (Italy)

^d UNIVERSITÉ DE TOULOUSE   (France)

^e ARISTOTLE UNIVERSITY OF THESSALONIKI   (Greece)

^f MEDICAL UNIVERSITY OF LODZ   (Poland)

^g UNIVERSITY OF EASTERN FINLAND   (Finland)

^h King s College London   (United Kingdom)

Author keywords

Alzheimer s disease; Freesurfer; MCI conversion; MRI; OPLS

Indexed keywords

ADULT; AGE; AGED; ALZHEIMER DISEASE; APOE EPSILON4 GENE; ARTICLE; AUTOMATED HIPPOCAMPAL SUBFIELD MEASUREMENT; AUTOMATION; BRAIN ATROPHY; BRAIN REGION; BRAIN SIZE; COHORT ANALYSIS; CONTROLLED STUDY; DIAGNOSTIC TEST ACCURACY STUDY; DIAGNOSTIC VALUE; EDUCATION; FEMALE; GENDER; GENE; GENOTYPE; HIPPOCAMPAL CA1 REGION; HIPPOCAMPUS; HUMAN; IMAGING SOFTWARE; MAJOR CLINICAL STUDY; MALE; MEASUREMENT ACCURACY; MILD COGNITIVE IMPAIRMENT; NEUROIMAGING; NEUROPSYCHOLOGICAL TEST; NUCLEAR MAGNETIC RESONANCE IMAGING; PRESUBICULUM; PRIORITY JOURNAL; SENSITIVITY AND SPECIFICITY; SUBICULUM; COGNITIVE DEFECT; FORECASTING; MIDDLE AGED; PATHOLOGY; PATHOPHYSIOLOGY; PHYSIOLOGY; PROCEDURES; VERY ELDERLY;

AGED; AGED, 80 AND OVER; ALZHEIMER DISEASE; COGNITIVE DYSFUNCTION; FEMALE; FORECASTING; HIPPOCAMPUS; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; NEUROPSYCHOLOGICAL TESTS;

EID: 84938744810     PISSN: 08960267     EISSN: 15736792     Source Type: Journal    
DOI: 10.1007/s10548-014-0415-1     Document Type: Article

References (56)

1. Apostolova LG et al (2006) Conversion of mild cognitive impairment to Alzheimer disease predicted by hippocampal atrophy maps. Arch Neurol 63(5):693–699
2. Apostolova LG et al (2010) 3D comparison of low, intermediate, and advanced hippocampal atrophy in MCI. Hum Brain Mapp 31(5):786–797
3. Barnes LL et al (2005) Sex differences in the clinical manifestations of Alzheimer disease pathology. Arch Gen Psychiatry 62(6):685–691
4. Braak H, Braak E (1991) Neuropathological stageing of Alzheimer-related changes. Acta Neuropathol 82(4):239–259
5. Bylesjo M et al (2006) OPLS discriminant analysis: combining the strengths of PLS-DA and SIMCA classification y. J Chemom 20:341–351
6. Costafreda SG et al (2011) Automated hippocampal shape analysis predicts the onset of dementia in mild cognitive impairment. Neuroimage 56(1):212–219
7. Csernansky JG et al (2005) Preclinical detection of Alzheimer’s disease: hippocampal shape and volume predict dementia onset in the elderly. Neuroimage 25(3):783–792
8. Dale AM, Fischl B, Sereno MI (1999) Cortical surface-based analysis. I. Segmentation and surface reconstruction. Neuroimage 9(2):179–194
9. Davatzikos C et al (2010) Prediction of MCI to AD conversion, via MRI, CSF biomarkers, and pattern classification. Neurobiol Aging 32(12):2322e19–2322e27
10. Desikan RS et al (2009) Automated MRI measures identify individuals with mild cognitive impairment and Alzheimer’s disease. Brain 132(8):2048–2057
11. Devanand DP et al (2007) Hippocampal and entorhinal atrophy in mild cognitive impairment: prediction of Alzheimer disease. Neurology 68(11):828–836
12. Dubois B et al (2007) Research criteria for the diagnosis of Alzheimer’s disease: revising the NINCDS-ADRDA criteria. Lancet Neurol 6(8):734–746
13. Fan Y et al (2008) Spatial patterns of brain atrophy in MCI patients, identified via high-dimensional pattern classification, predict subsequent cognitive decline. Neuroimage 39(4):1731–1743
14. Fischl B et al (2002) Whole brain segmentation: automated labeling of neuroanatomical structures in the human brain. Neuron 33(3):341–355
15. Fischl B et al (2004) Sequence-independent segmentation of magnetic resonance images. Neuroimage 23(Suppl 1):S69–S84
16. Fox NC et al (1996) Presymptomatic hippocampal atrophy in Alzheimer’s disease. A longitudinal MRI study. Brain 119(Pt 6):2001–2007
17. Frisoni GB et al (2010) The clinical use of structural MRI in Alzheimer disease. Nat Rev Neurol 6(2):67–77
18. Furney, SJ et al (2011) Combinatorial markers of mild cognitive impairment conversion to Alzheimer’s disease–cytokines and MRI measures together predict disease progression. J Alzheimers Dis 26(Suppl 3(3)):395–405
19. Gouras GK et al (2000) Testosterone reduces neuronal secretion of Alzheimer’s β-amyloid peptides. Proc Natl Acad Sci USA 97(3):1202–1205
20. Hanseeuw BJ et al (2011) Mild cognitive impairment: differential atrophy in the hippocampal subfields. AJNR Am J Neuroradiol 32(9):1658–1661
21. Jack CR et al (1992) MR-based hippocampal volumetry in the diagnosis of Alzheimer’s disease. Neurology 42(1):183–188
22. Jack CR et al (1998) Hippocampal atrophy and apolipoprotein E genotype are independently associated with Alzheimer’s disease. Ann Neurol 43(3):303–310
23. Jack CR et al (2008) The Alzheimer’s disease neuroimaging initiative (ADNI): MRI methods. J Magn Reson Imaging 27(4):685–691
24. Karas G et al (2008) Amnestic mild cognitive impairment: structural MR imaging findings predictive of conversion to Alzheimer disease. AJNR Am J Neuroradiol 29(5):944–949
25. Klöppel S et al (2008) Automatic classification of MR scans in Alzheimer’s disease. Brain 131(Pt 3):681–689
26. Lerch JP et al (2008) Automated cortical thickness measurements from MRI can accurately separate Alzheimer’s patients from normal elderly controls. Neurobiol Aging 29(1):23–30
27. Liu Y et al (2009) Combination analysis of neuropsychological tests and structural MRI measures in differentiating AD, MCI and control groups-The AddNeuroMed study. Neurobiol Aging 32(7):1198–1206
28. Lovestone S et al (2009) AddNeuroMed–the European collaboration for the discovery of novel biomarkers for Alzheimer’s disease. Ann N Y Acad Sci 1180:36–46
29. Mangialasche F et al (2010) High plasma levels of vitamin E forms and reduced Alzheimer’s disease risk in advanced age. J Alzheimers Dis 20(4):1029–1037
30. McEvoy LK et al (2009) Alzheimer disease: quantitative structural neuroimaging for detection and prediction of clinical and structural changes in mild cognitive impairment. Radiology 251(1):195–205
31. Misra C, Fan Y, Davatzikos C (2009) Baseline and longitudinal patterns of brain atrophy in MCI patients, and their use in prediction of short-term conversion to AD: results from ADNI. Neuroimage 44(4):1415–1422
32. Mueller SG, Weiner MW (2009) Selective effect of age, Apo e4, and Alzheimer’s disease on hippocampal subfields. Hippocampus 19(6):558–564
33. Mueller SG et al (2010) Hippocampal atrophy patterns in mild cognitive impairment and Alzheimer’s disease. Hum Brain Mapp 31(9):1339–1347
34. Plant C et al (2010) Automated detection of brain atrophy patterns based on MRI for the prediction of Alzheimer’s disease. Neuroimage 50(1):162–174
35. Reiman EM et al (1998) Hippocampal volumes in cognitively normal persons at genetic risk for Alzheimer’s disease. Ann Neurol 44(2):288–291
36. Robin X et al (2011) pROC: an open-source package for R and S + to analyze and compare ROC curves. Bioinformatics 12(1):77
37. Scheltens P et al (1992) Atrophy of medial temporal lobes on MRI in “probable” Alzheimer’s disease and normal ageing: diagnostic value and neuropsychological correlates. J Neurol Neurosurg Psychiatry 55(10):967–972
38. Ségonne F et al (2004) A hybrid approach to the skull stripping problem in MRI. Neuroimage 22(3):1060–1075
39. Simmons A et al (2009) MRI measures of Alzheimer’s disease and the AddNeuroMed study. Ann N Y Acad Sci 1180:47–55
40. Simmons A et al (2011) The AddNeuroMed framework for multi-centre MRI assessment of Alzheimer’s disease: experience from the first 24 months. Int J Geriatr Psychiatry 26(1):75–82
41. Spulber G et al (2013) An MRI-based index to measure the severity of Alzheimer’s disease-like structural pattern in subjects with mild cognitive impairment. J Intern Med 273(4):396–409
42. Trygg J, Wold S (2002) Orthogonal projections to latent structures (O-PLS). J Chemom 16(3):119–128
43. Van Leemput K et al (2009) Automated segmentation of hippocampal subfields from ultra-high resolution in vivo MRI. Hippocampus 19(6):549–557
44. Vemuri P et al (2008) Alzheimer’s disease diagnosis in individual subjects using structural MR images: validation studies. Neuroimage 39(3):1186–1197
45. Vemuri P et al (2009) MRI and CSF biomarkers in normal, MCI, and AD subjects: predicting future clinical change. Neurology 73(4):294–301
46. West MJ et al (2004) Hippocampal neurons in pre-clinical Alzheimer’s disease. Neurobiol Aging 25(9):1205–1212
47. Westman E, Wahlund LO, Foy C et al (2010) Combining MRI and MRS to distinguish between Alzheimer’s disease and healthy controls. J Alzheimers Dis 22(1):171–181
48. Westman E, Simmons A, Muehlboeck J-S et al (2011a) AddNeuroMed and ADNI: similar patterns of Alzheimer’s atrophy and automated MRI classification accuracy in Europe and North America. Neuroimage 58(3):818–828
49. Westman E, Wahlund L, Foy C et al (2011b) Magnetic Resonance Imaging and Magnetic Resonance Spectroscopy for Detection of Early Alzheimer’ s Disease. J Alzheimers Dis 26:307–319
50. Westman E, Simmons A, Zhang Y et al (2011c) Multivariate analysis of MRI data for Alzheimer’s disease, mild cognitive impairment and healthy controls. Neuroimage 54(2):1178–1187
51. Westman E, Cavallin L, Muehlboeck J-S et al (2011d) Sensitivity and Specificity of Medial Temporal Lobe Visual Ratings and Multivariate Regional MRI Classification in Alzheimer’s Disease J. Laks, ed. PLoS One 6(7):9
52. Westman E, Muehlboeck J-S, Simmons A (2012) Combining MRI and CSF measures for classification of Alzheimer’s disease and prediction of mild cognitive impairment conversion. Neuroimage 62(1):229–238
53. Westman E et al (2013) Regional magnetic resonance imaging measures for multivariate analysis in Alzheimer’s disease and mild cognitive impairment. Brain Topogr 26(1):9–23
54. Wiklund S et al (2008) Visualization of GC/TOF-MS-based metabolomics data for identification of biochemically interesting compounds using OPLS class models. Anal Chem 80(1):115–122
55. Wolz R et al (2011) Multi-method analysis of MRI images in early diagnostics of Alzheimer’s disease. PLoS One 6(10):e25446
56. Zhang D et al (2011) Multimodal classification of Alzheimer’s disease and mild cognitive impairment. Neuroimage 55(3):856–867